In Section A, individuals will receive different doses and schedules of oral ABBV-744 tablet to determine Secure dosing program. More individuals will probably be enrolled in the discovered monotherapy dosign routine. In Section B, contributors will get oral ruxolitinib and ABBV-744 will likely be o